{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:48:56Z","timestamp":1791431336400,"version":"4.3.3"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014943","name":"Sarepta Therapeutics","doi-asserted-by":"publisher","award":["MA 02142"],"award-info":[{"award-number":["MA 02142"]}],"id":[{"id":"10.13039\/100014943","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jbc.2022.102675","type":"journal-article","created":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T07:20:02Z","timestamp":1668151202000},"page":"102675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Enhancing interaction of actin and actin-binding domain 1 of dystrophin with modulators: Toward improved gene therapy for Duchenne muscular dystrophy"],"prefix":"10.1016","volume":"298","author":[{"given":"Piyali","family":"Guhathakurta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dillon","family":"Kurila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"LaFrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake R.","family":"Trask","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bri","family":"Vanderheyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Muretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Ervasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8822-2040","authenticated-orcid":false,"given":"David D.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2022.102675_bib1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2022.102675_bib2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1083\/jcb.139.2.375","article-title":"Animal models for muscular dystrophy show different patterns of sarcolemmal disruption","volume":"139","author":"Straub","year":"1997","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jbc.2022.102675_bib3","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","article-title":"Dystrophin protects the sarcolemma from stresses developed during muscle contraction","volume":"90","author":"Petrof","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2022.102675_bib4","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1083\/jcb.122.4.809","article-title":"A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin","volume":"122","author":"Ervasti","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jbc.2022.102675_bib5","doi-asserted-by":"crossref","first-page":"689533","DOI":"10.3389\/fcell.2021.689533","article-title":"Current pharmacological strategies for duchenne muscular dystrophy","volume":"9","author":"Yao","year":"2021","journal-title":"Front Cell Dev Biol."},{"key":"10.1016\/j.jbc.2022.102675_bib6","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.ymthe.2017.02.019","article-title":"Progress toward gene therapy for duchenne muscular dystrophy","volume":"25","author":"Chamberlain","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jbc.2022.102675_bib7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/14712598.2020.1725469","article-title":"Clinical development on the frontier: gene therapy for duchenne muscular dystrophy","volume":"20","author":"Asher","year":"2020","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.jbc.2022.102675_bib8","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/j.2040-4603.2015.tb00638.x","article-title":"The dystrophin complex: structure, function, and implicat ions for therapy","volume":"5","author":"Gao","year":"2015","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.jbc.2022.102675_bib9","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1093\/hmg\/ddm158","article-title":"Functional capacity of dystrophins carrying deletions in the N-terminal actin-binding domain","volume":"16","author":"Banks","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2022.102675_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000958","article-title":"The polyproline site in hinge 2 influences the functional capacity of truncated dystrophins","volume":"6","author":"Banks","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jbc.2022.102675_bib11","doi-asserted-by":"crossref","first-page":"28419","DOI":"10.1074\/jbc.273.43.28419","article-title":"A cluster of basic repeats in the dystrophin rod domain binds F-actin through an electrostatic interaction","volume":"273","author":"Amann","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2022.102675_bib12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1083\/jcb.135.3.661","article-title":"A new model for the interaction of dystrophin with F-actin","volume":"135","author":"Rybakova","year":"1996","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jbc.2022.102675_bib13","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1074\/jbc.M513121200","article-title":"Dystrophin and utrophin bind actin through distinct modes of contact","volume":"281","author":"Rybakova","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2022.102675_bib14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jmb.2011.12.040","article-title":"The carboxy-terminal third of dystrophin enhances actin binding activity","volume":"416","author":"Henderson","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jbc.2022.102675_bib15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/73456","article-title":"Mutations in ACTN4, encoding alpha - actinin-4, cause familial focal segmental glomerulosclerosis","volume":"24","author":"Kaplan","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jbc.2022.102675_bib16","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/hmg\/ddp442","article-title":"Skeletal dysplasias due to filamin A mutations result from a gain-of-function mechanism distinct from allelic neurologica l disorders","volume":"18","author":"Clark","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2022.102675_bib17","doi-asserted-by":"crossref","first-page":"21375","DOI":"10.1038\/srep21375","article-title":"A human beta-III-spectrin spinocerebellar ataxia type 5 mutation causes high-affinity F-actin binding","volume":"6","author":"Avery","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2022.102675_bib18","doi-asserted-by":"crossref","first-page":"103101","DOI":"10.1063\/1.3480647","article-title":"High-performance time-resolved fluorescence by direct waveform recording","volume":"81","author":"Muretta","year":"2010","journal-title":"Rev. Sci. Instrum."},{"key":"10.1016\/j.jbc.2022.102675_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1242\/jcs.108.1.63","article-title":"Utrophin actin binding domain: Analysis of actin binding and cellular targeting","volume":"108","author":"Winder","year":"1995","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jbc.2022.102675_bib20","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1021\/acs.biochem.5b00741","article-title":"Interdomain linker determines primarily the structural stability of dystrophin and utrophin tandem calponin-homology domains rather than their actin- binding affinity","volume":"54","author":"Bandi","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2022.102675_bib21","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1021\/bi500149q","article-title":"The actin binding affinity of the utrophin tandem calponin-homology domain is primarily determined by its N-terminal domain","volume":"53","author":"Singh","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2022.102675_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jmb.2012.04.005","article-title":"Impacts of dystrophin and utrophin domains on actin structural dynamics: implications for therapeutic design","volume":"420","author":"Lin","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jbc.2022.102675_bib23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jmb.2012.02.011","article-title":"Structural and functional dynamics of an integral membrane protein complex modulated by lipid headgroup charge","volume":"418","author":"Li","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jbc.2022.102675_bib24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bpj.2017.05.027","article-title":"A cardiomyopathy mutation in the myosin essential light chain alters actomyosin structure","volume":"113","author":"Guhathakurta","year":"2017","journal-title":"Biophys. J."},{"key":"10.1016\/j.jbc.2022.102675_bib25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1087057113510740","article-title":"Discovery of enzyme modulators via high-throughput time- resolved FRET in living cells","volume":"19","author":"Gruber","year":"2014","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.jbc.2022.102675_bib26","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/(SICI)1097-0169(1998)41:3<264::AID-CM7>3.0.CO;2-Z","article-title":"Dystrophin binding to nonmusc le actin","volume":"41","author":"Renley","year":"1998","journal-title":"Cell Motil. Cytoskelet."},{"key":"10.1016\/j.jbc.2022.102675_bib27","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1091\/mbc.E19-06-0317","article-title":"Steric regulation of tandem calponin homology domain actin-binding affinity","volume":"30","author":"Harris","year":"2019","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jbc.2022.102675_bib28","doi-asserted-by":"crossref","first-page":"E1796","DOI":"10.1073\/pnas.1611698114","article-title":"Heart failure drug changes the mechanoenzymology of the cardiac myosin powerstroke","volume":"114","author":"Rohde","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2022.102675_bib29","doi-asserted-by":"crossref","first-page":"12288","DOI":"10.1074\/jbc.RA118.002702","article-title":"High- throughput screen, using time-resolved FRET, yields actin-binding compounds that modulate actin- myosin structure and function","volume":"293","author":"Guhathakurta","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2022.102675_bib30","doi-asserted-by":"crossref","first-page":"100215","DOI":"10.1074\/jbc.RA120.015417","article-title":"Novel drug discovery platform for spinocerebellar ataxia, using fluoresce nce technology targeting beta-III-spectrin","volume":"296","author":"Rebbeck","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2022.102675_bib31","doi-asserted-by":"crossref","first-page":"100840","DOI":"10.1016\/j.jbc.2021.100840","article-title":"Cardiac myosin-binding protein C interaction with actin is inhibited by compounds identified in a high-throughput fluorescence lifetime screen","volume":"297","author":"Bunch","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2022.102675_bib32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.jbc.2022.102675_bib33","doi-asserted-by":"crossref","first-page":"14100","DOI":"10.1074\/jbc.RA120.014445","article-title":"Actin-binding compounds, previously discovered by FRET-based high-throughput screening, differentially affect skeletal and cardiac muscle","volume":"295","author":"Guhathakurta","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2022.102675_bib34","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jbc.2022.102675_bib35","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1634\/stemcells.2006-CSC2","article-title":"The molecular perspective: cisplatin","volume":"24","author":"Goodsell","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.jbc.2022.102675_bib36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pep.2015.08.019","article-title":"Tandem SUMO fusion vectors for improving soluble protein expression and purification","volume":"116","author":"Guerrero","year":"2015","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.jbc.2022.102675_bib37","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1073\/pnas.1420101112","article-title":"Amplitude of the actomyosin power stroke depends strongly on the isoform of the myosin essential light chain","volume":"112","author":"Guhathakurta","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2022.102675_bib38","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/1087057116680151","article-title":"High-throughput spectral and lifetime-based FRET screening in living cells to identify small-molecule effectors of SERCA","volume":"22","author":"Schaaf","year":"2017","journal-title":"SLAS Discov."},{"key":"10.1016\/j.jbc.2022.102675_bib39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/1087057116674312","article-title":"High-throughput screens to discover small-molecule modulators of Ryanodine Receptor calcium Release channels","volume":"22","author":"Rebbeck","year":"2017","journal-title":"SLAS Discov."},{"key":"10.1016\/j.jbc.2022.102675_bib40","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3390\/cells9051170","article-title":"Live-cell cardiac-specific high-throughput screening platform for drug- like molecules that enhance Ca(2+) Transport","volume":"9","author":"Schaaf","year":"2020","journal-title":"Cells"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925822011188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925822011188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:54:53Z","timestamp":1777409693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925822011188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0021925822011188"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2022.102675","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing interaction of actin and actin-binding domain 1 of dystrophin with modulators: Toward improved gene therapy for Duchenne muscular dystrophy","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2022.102675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"102675"}}